Enliven: Pharmacovigilance and Drug Safety

Author Invitation Submit Manuscript
Journal Sections
Pharmacovigilance Signal
The relationship between drug and the adverse event to allow drug to act.
Pharmacovigilance Data Management
Generation of reliable and statistical data from pharmacovigilance studies.
Design and Development of Drug
Rational designing and developing drugs based on the biological targets.
Principles of Pharmacology
The principles to understand and predict drug effects in human body.
Quality System and Pharmacovigilance
The process of monitoring the licensed drug effects to identify and evaluate unreported adverse reactions.
Pharmacovigilance Softwares
Softwares developed to run the pharmacovigilance steps.
Drug Regulatory Activities
The process of protecting public health by controlling the safety and efficacy of pharmaceutical drugs.
Drug Reactions and Diagnosis
Study and diagnosis of drug reactions over the biological targets.
Clinical Trials and Pharmacovigilance
The research investigations in pharmacovigilance to test new treatments, interventions to prevent various diseases.
Marketing Surveillance
The process of monitoring drug after its release in the market.
Pharmacovigilance Ethics and Regulations
Basic principles and ethics in pharmacovigilance.
Biomarkers and Pharmacology
The process of using biomarkers in pharmacology to track the drug actions.
Concepts and Trends in Pharmacovigilance
Current enhancements and trends in the field of pharmacovigilance.
Drug Delivery Systems
The path, approach, and transport of drugs to reach the biological target.
Clinical Pharmacovigilance
The clinical approach to deal with drug discovery and drug delivery.
Periodic Safety Update Reports
Reports used to provide a safety update on medicinal product.
Good Pharmacovigilance Practice
The good practical approaches in pharmacovigilance set by European Union to evaluate the processes.
Pharmacovigilance Regulatory Updates
Regulatory update reports of pharmacovigilance.
Drug Safety Survillance
The process of monitoring drug through the entire drug pathway.
Pharmacovigilance for Alternative Medicine
Process to handle alternative medicine post marketing clinical trials.
Europe Pharmacovigilance
Good Pharmacovigilance Practice in European Union.
US Pharmacovigilance
Good Pharmacovigilance Practice in United States.
Japan Pharmacovigilance
Good Pharmacovigilance Practice in Japan.
UK Pharmacovigilance
Good Pharmacovigilance Practice in United Kingdom.
Pharmacovigilance Methods
Several methods included in Pharmacovigilance.
Drug Related Problems in Health Care
Adverse affects and adverse events of the pharmaceutical drugs.
Clinical Drug Manifestations of Adverse Drug Reactions
Study of adverse drug reactions.
Medical Evaluation of Adverse Events
To monitor the adverse events in the body and to evaluate the usage of medicine.
Journal Features
  • All submissions will undergo vigorous peer review process.
  • High quality review process.
  • Permanent published archives.
  • Author loyal benefits.
  • Reviewer credits.
  • Visible specified citations.
  • Open access - Maximum dissemination.
  • Un-interrupted author communication.
  • Standard author guidelines.
  • Minimal publication charges with convenient and safe modes of transfer.
About

AIM

SCOPE

OPEN ACCESS

PUBLICATION ETHICS

JOURNAL FEATURES

AIM: 

Enliven: Pharmacovigilance and Drug Safety aims to become one of the most popular Open access journals in the science field and to follow flawless review process with high quality articles.

Journal provides a common platform for editors, reviewers, authors, and readers to have an uninterrupted scientific communication. In order to become the leading journal, Enliven: Pharmacovigilance and Drug Safetyprovide wide scope which allows and accepts articles from multiple disciplines and guides the articles according to the peer review process. 

Journal processes different types of articles viz. research, review, case reports, technical reports, editorials, letters, letter to editors, commentaries, short communications, conference proceedings, announcements, rapid communications, addendums, book reviews, concept papers, abstracts, graphical abstracts, discussions, errata, project report, and expression of concerns. There is no limit for the article length. Journal aim is to encourage scientists, academicians, students, and many other authors to publish their work as elaborate as they can.

SCOPE:

Enliven: Pharmacovigilance and Drug Safety provides wide scope for the authors, readers in all possible fields. Journal emboldens authors with its rigid peer review process and journal follows stringent editorial policies to avoid all publishing discrepancies. 

Enliven: Pharmacovigilance and Drug Safety is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in journal fields. It also aims to follow flawless review process with high quality articles. This journal aims to become one of the leading journals which aid scientific community in knowledge dissemination. This journal provides a huge platform for editors, reviewers, authors, and readers to have an uninterrupted scientific communication. In order to become the leading journal, Enliven: Pharmacovigilance and Drug Safety provide wide scope which allows and accepts articles from multiple disciplines and guides the articles according to the peer review process.

Enliven: Pharmacovigilance and Drug Safety looks forward for the diverse submissions to disseminate the information about current discoveries and developments in the journal field. Journal has unique editorial board to take care of publishing activities in organized way. Journal policies are coined to allow flexible communications among different groups of journal members and to allow the journal to follow the strict rules.

OPEN ACCESS:

Journal’s main motto is to promote open access and sustain in the open access field with new approaches and to widen the chances in open access which will create a new turn in current era

As journal is anopen access, we seek support from scientific community, industries, funding agencies, universities, institutes, and any others interested in publications

Journal believes that scientific information must be accessible to everyone without any barriers.

Journalcharges the authors with very minimal publication charges and depends on our users those who support global commons. Journal, also has the policy of providing reliable mark-downs on the charges based on the submission to encourage every author. 

We thank all the support from users and we wish to spread the word “Enliven Archive – Intensifying thoughts” to all your colleagues and people in your track.

PUBLICATION ETHICS:

Journal follows certain publication standards publishing manuscripts. This ensures that we deliver quality research with high standards, develops and retains the trust of authors.

Plagiarism:

Journal checks for plagiarism before peer review process. Upon generation of clear reports, we launch the manuscript process.

Journal rejects manuscripts with high plagiarism scores and does not allow the manuscripts to proceed further for peer review process.

To avoid conflicts, we suggest the authors to submit the plagiarism free content. 

Authors may include self-plagiarized content, providing the citations of their previous work.

Authors can resubmit the rejected manuscripts on plagiarism base by carrying out all the corrections and such manuscripts will be considered as new submissions and will undergo the whole process again regardless the stage of the process the article existing before.

Redundant Submissions:

Already published manuscripts and/or manuscripts under process elsewhere are redundant submissions and we reject such submissions from the process immediately. Authors need to look over the publication transfer issues in certain cases else, we reject the manuscript.

Citations Usage:

Manuscripts should avoid the usage of un-wanted citations that improves the quality of articles.

False Data:

Manuscripts should contain original data of experiments, statistics or any entries and authors should not either mimic or plagiarize other manuscripts.

Author Contribution:

Manuscripts should contain the list of authors those who have contributed to the manuscript. Author contribution should contain all authors those who have contributed to the manuscript that may include lab assistants, technicians, and others.

JOURNAL FEATURES:

Copyright Statements:

Author gets Open Access Creative Commons License after publishing the work with the journal as we are covered under Creative Commons Attribution 3.0 Unported License. We transfer complete ownership for published content to the author based on this license. This License will permit the reader only to download printout, extract, reuse and distribute the article with appropriate credits to the corresponding author.

Unique Identifiers:

Enliven: Pharmacovigilance and Drug Safetyis a member of CrossRef and all the published articles will be assigned with unique article object identifiers (DOIs).

Reprints:

Journal also provides print versions upon the order of authors or any other users with unique citation and by having no change in the published article with minimal reprint charges.